Recent Finacing
Recent Raise
Mogrify develops a platform using NGS and gene‑regulatory network analytics to identify transcriptional and epigenetic factors that enable direct cellular conversion for in vivo reprogramming and ex vivo therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
